Observing Radiation Treatment Choices and Outcomes Using Stereotactic Body Radiotherapy SBRT vs Conventional Radiotherapy CRT for Adults with Painful Spinal Metastases

What this Trial Is About

Researchers are observing how radiation oncologists decide between stereotactic body radiotherapy SBRT and conventional radiotherapy CRT for patients with spinal metastases. This observational study aims to compare real-world outcomes such as local tumor progression, pain relief, and overall survival for these two radiation treatments. The study will help develop an evidence-based guide to support treatment decisions for spinal metastases in the future. Participants will receive either SBRT or CRT as part of their standard care according to institutional guidelines. Radiation oncologists will complete questionnaires to share their decision-making processes. The study collects data on treatment choice and patient outcomes over time without altering the care patients receive. During the study, patients will be monitored for local progression of their spinal tumors, changes in pain levels, adverse events, and overall survival for up to two years. Researchers will gather information through medical records and questionnaires to understand treatment effects and decision factors. Participation involves regular follow-up visits and assessments as part of routine care, with no experimental interventions being assigned.

Comparing SBRT to CRT in Patients With Spinal Metastases